Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Tuberculosis | Research article

Minnesota refugees diagnosed with tuberculosis disease, January 1993–August 2019

Authors: Kailey Urban, Blain Mamo, Dzung Thai, Alicia Earnest, Emily Jentes

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Refugees are screened for TB overseas using Technical Instructions (TIs) issued by the U.S. Centers for Disease Control and Prevention and after arrival during their refugee health assessment (RHA). We examined RHA results and TB outcomes of refugees to Minnesota.

Methods

Demographic and RHA results for 70,290 refugee arrivals to Minnesota from January 1993 to August 2019 were matched to 3595 non-U.S. born individuals diagnosed with TB disease during that time.

Results

Seven hundred fifty-nine (1.1%) were diagnosed with TB disease. Fifty-four percent were diagnosed within 2 years of U.S. arrival. Refugees screened using TIs implemented in 1991 were twice as likely to be diagnosed with TB disease within 1 year of arrival, compared to those evaluated using improved TIs implemented in 2007.

Conclusion

Few refugees were diagnosed with TB disease during the period examined. Enhancements to overseas protocols significantly reduced the proportion of refugees diagnosed within 1 year of arrival.
Literature
1.
Talwar A, Tsang CA, Price SF, Pratt RH, Walker WL, Schmit KM, Langer AJ. Tuberculosis—United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(11):257–62.CrossRef
2.
Yuen CM, Kammerer JS, Marks K, Navin TR, France AM. Recent transmission of tuberculosis—United States, 2011–2014. PLoS ONE. 2016;11(4):e0153728.
3.
4.
Centers for Disease Control and Prevention. Notice to readers: revised technical instructions for tuberculosis screening and treatment for panel physicians. MMWR Morb Mortal Wkly Rep. 2008;57(11):292–3.
5.
6.
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O’Brien R, Peloquin CA, Raftery A, Saukkonen J, Shaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63(7):e147–95.CrossRef
7.
8.
9.
Lee D, Philen R, Wang Z, McSpadden P, Posey DL, Ortega LS, Weinberg MS, Brown C, Zhou W, Painter JA. Disease surveillance among newly arriving refugees and immigrants—Electronic Disease Notification System, United States, 2009. MMWR Surveill Summ. 2013;62(7):1–20.PubMed
10.
Liu Y, Weinberg MS, Ortega LS, Painter JA, Maloney SA. Overseas screening for tuberculosis in U.S.-bound immigrants and refugees. N Engl J Med. 2009;360(23):2406–15.
11.
Cain KP, Benoit SR, Winston CA. Tuberculosis among foreign-born persons in the United States. JAMA. 2008;300:405–12.CrossRef
12.
Liu Y, Posey DL, Cetron MS, Painter JA. Effect of culture-based screening algorithm on tuberculosis incidence in immigrants and refugees bound for the United States: a population-based cross-sectional study. Ann Intern Med. 2015;162(6):420–8.CrossRef
13.
Posey DL, Naughton MP, Willacy EA, Russell M, Olson CK, Godwin CM, McSpadden PS, White ZA, Comans TW, Ortega LS, Guterbock M, Weinberg MS, Cetron MS. Implementation of new TB screening requirements for U.S.-bound immigrants and refugees—2007–2014. MMWR Morb Mortal Wkly Rep. 2014;63(11):234–6.
14.
Maskery B, Posey DL, Coleman MS, Asis R, Painter JA, Wingate LT, Roque M, Cetron MS. Economic analysis of CDC’s culture and smear-based tuberculosis instructions for Filipino immigrants. Int J Tuberc Lung Dis. 2018;22(4):429–36.CrossRef
15.
Lowenthal P, Westenhouse J, Moore M, Posey DL, Watt JP, Flood J. Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol. Int J Tuberc Lung Dis. 2011;15(6):761–6.CrossRef
16.
Baker BJ, Winston CA, Liu Y, France AM, Cain KP. Abrupt decline in tuberculosis among foreign-born persons in the United States. PLoS ONE. 2016;11:e0147353.
17.
Varkey P, Jerath AU, Bagniewski SM, Lesnick TG. The epidemiology of tuberculosis among primary refugee arrivals in Minnesota between 1997 and 2001. J Travel Med. 2007;14(1):1–8.CrossRef
18.
Trauer JM, Krause VL. Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory. Med J Aust. 2011;194(11):579–82.CrossRef
19.
Levesque JF, Dongier P, Brassard P, Allard R. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis. 2004;8(6):711–7.PubMed
20.
Hirsch-Moverman Y, Daftary A, Franks J, Colson PW. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis. 2008;12(11):1235–54.PubMed
21.
Benjumea-Bedoya D, Becker M, Haworth-Brockman M, Balakumar S, Hiebert K, Lutz J-A, Farough AB, Keynan Y, Plourde P. Integrated care for latent tuberculosis infection (LTBI) at a primary health care facility for refugees in Winnipeg, Canada: a mixed-methods evaluation. Front Public Health. 2019;7:57.CrossRef
22.
Duchen D, Boyd AT, Annamalai A. Screening and treatment rates for latent tuberculosis among newly-arrived refugees in an urban facility in Connecticut. Conn Med. 2017;81(5):291–8.PubMed
23.
Subedi P, Drezner KA, Dogbey MC, Newbern EC, Yun K, Scott KC, Garland JM, Altschuler MJ, Johnson CC. Evaluation of latent tuberculous infection and treatment completion for refugees in Philadelphia, PA, 2010–2012. Int J Tuberc Lung Dis. 2015;19(5):565–9.CrossRef
24.
Nuzzo JB, Golub JE, Chaulk P, Shah M. Analysis of latent tuberculosis infection treatment adherence among refugees and other patient groups referred to the Baltimore City Health Department TB clinic, February 2009–March 2011. J Immigr Minor Health. 2015;17(1):56–65.CrossRef
25.
26.
27.
Tsang CA, Langer AJ, Navin TR, Armstrong LR. Tuberculosis among foreign-born persons diagnosed ≥10 years after arrival in the United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2017;66(11):295–8.CrossRef
28.
Benoit SR, Gregg EW, Jonnalagadda S, Phares CR, Zhou W, Painter JA. Association of diabetes and tuberculosis disease among US-bound adult refugees, 2009–2014. Emerg Infect Dis. 2017;23(3):543–5.CrossRef
Metadata
Title
Minnesota refugees diagnosed with tuberculosis disease, January 1993–August 2019
Authors
Kailey Urban
Blain Mamo
Dzung Thai
Alicia Earnest
Emily Jentes
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07327-0

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue

Research

Progression of severity in coronavirus disease 2019 patients before treatment and a self-assessment scale to predict disease severity

Research

Comprehensive knowledge about HIV/AIDS and associated factors among women of reproductive age in sub-Saharan Africa: a multilevel analysis using the most recent demographic and health survey of each country

Case report

Concurrent severe pulmonary tuberculosis with Evans syndrome: a case report with literature review

Research

Knowledge, attitude, and practices regarding childhood tuberculosis detection and management among healthcare providers in Cambodia: a cross-sectional study

Study protocol

Evaluation of droplet digital PCR rapid detection method and precise diagnosis and treatment for suspected sepsis (PROGRESS): a study protocol for a multi-center pragmatic randomized controlled trial

Study protocol

Resistance to single dose albendazole and reinfection with intestinal helminths among children ages 2 to 11 years from the Peruvian Amazon region: a study protocol

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits